177 related articles for article (PubMed ID: 12366604)
1. Cholesterol treatment forever? The first Scandinavian trial of cholesterol supplementation in the cholesterol-synthesis defect Smith-Lemli-Opitz syndrome.
Starck L; Lövgren-Sandblom A; Björkhem I
J Intern Med; 2002 Oct; 252(4):314-21. PubMed ID: 12366604
[TBL] [Abstract][Full Text] [Related]
2. Sterol balance in the Smith-Lemli-Opitz syndrome. Reduction in whole body cholesterol synthesis and normal bile acid production.
Steiner RD; Linck LM; Flavell DP; Lin DS; Connor WE
J Lipid Res; 2000 Sep; 41(9):1437-47. PubMed ID: 10974051
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome.
Linck LM; Lin DS; Flavell D; Connor WE; Steiner RD
Am J Med Genet; 2000 Aug; 93(5):360-5. PubMed ID: 10951458
[TBL] [Abstract][Full Text] [Related]
4. Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome.
Chan YM; Merkens LS; Connor WE; Roullet JB; Penfield JA; Jordan JM; Steiner RD; Jones PJ
Pediatr Res; 2009 Jun; 65(6):681-5. PubMed ID: 19430384
[TBL] [Abstract][Full Text] [Related]
5. No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome.
Roullet JB; Merkens LS; Pappu AS; Jacobs MD; Winter R; Connor WE; Steiner RD
J Inherit Metab Dis; 2012 Sep; 35(5):859-69. PubMed ID: 22391996
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and Clinical Effects of Vitamin E Supplementation in Hungarian Smith-Lemli-Opitz Syndrome Patients.
Koczok K; Horváth L; Korade Z; Mezei ZA; Szabó GP; Porter NA; Kovács E; Mirnics K; Balogh I
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439893
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of Smith-Lemli-Opitz syndrome by ultraviolet spectrophotometry.
Scalco FB; Cruzes VM; Vendramini RC; Brunetti IL; Moretti-Ferreira D
Braz J Med Biol Res; 2003 Oct; 36(10):1327-32. PubMed ID: 14502364
[TBL] [Abstract][Full Text] [Related]
8. Feedback inhibition of the cholesterol biosynthetic pathway in patients with Smith-Lemli-Opitz syndrome as demonstrated by urinary mevalonate excretion.
Pappu AS; Steiner RD; Connor SL; Flavell DP; Lin DS; Hatcher L; Illingworth DR; Connor WE
J Lipid Res; 2002 Oct; 43(10):1661-9. PubMed ID: 12364550
[TBL] [Abstract][Full Text] [Related]
9. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.
Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N
J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biochemical screening for Smith-Lemli-Opitz syndrome. Italian SLOS Collaborative Group.
Guzzetta V; De Fabiani E; Galli G; Colombo C; Corso G; Lecora M; Parenti G; Strisciuglio P; Andria G
Acta Paediatr; 1996 Aug; 85(8):937-42. PubMed ID: 8863875
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol supplementation objectively reduces photosensitivity in the Smith-Lemli-Opitz syndrome.
Azurdia RM; Anstey AV; Rhodes LE
Br J Dermatol; 2001 Jan; 144(1):143-5. PubMed ID: 11167696
[TBL] [Abstract][Full Text] [Related]
12. Variant RSH/Smith-Lemli-Opitz syndrome with atypical sterol metabolism.
Anderson AJ; Stephan MJ; Walker WO; Kelley RI
Am J Med Genet; 1998 Aug; 78(5):413-8. PubMed ID: 9714006
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders.
Svoboda MD; Christie JM; Eroglu Y; Freeman KA; Steiner RD
Am J Med Genet C Semin Med Genet; 2012 Nov; 160C(4):285-94. PubMed ID: 23042642
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome.
Sikora DM; Ruggiero M; Petit-Kekel K; Merkens LS; Connor WE; Steiner RD
J Pediatr; 2004 Jun; 144(6):783-91. PubMed ID: 15192627
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS).
Elias ER; Irons MB; Hurley AD; Tint GS; Salen G
Am J Med Genet; 1997 Jan; 68(3):305-10. PubMed ID: 9024564
[TBL] [Abstract][Full Text] [Related]
16. Smith-Lemli-Opitz Syndrome in a newborn infant with developmental abnormalities and low endogenous cholesterol.
Yang Y; Yassan L; Leung EKY; Yeo KJ
Clin Chim Acta; 2018 Apr; 479():208-211. PubMed ID: 29355488
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin treatment in the SLO syndrome: a safe approach?
Starck L; Lövgren-Sandblom A; Björkhem I
Am J Med Genet; 2002 Nov; 113(2):183-9. PubMed ID: 12407710
[TBL] [Abstract][Full Text] [Related]
18. Relation between biomarkers and clinical severity in patients with Smith-Lemli-Opitz syndrome.
Oláh AV; Szabó GP; Varga J; Balogh L; Csábi G; Csákváry V; Erwa W; Balogh I
Eur J Pediatr; 2013 May; 172(5):623-30. PubMed ID: 23319240
[TBL] [Abstract][Full Text] [Related]
19. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.
Salen G; Tint GS; Xu G; Batta AK; Irons M; Elias ER
Ital J Gastroenterol; 1995 Dec; 27(9):506-8. PubMed ID: 8919321
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol storage defect in RSH/Smith-Lemli-Opitz syndrome fibroblasts.
Wassif CA; Vied D; Tsokos M; Connor WE; Steiner RD; Porter FD
Mol Genet Metab; 2002 Apr; 75(4):325-34. PubMed ID: 12051964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
